Evidence map›Paper›PMID 38744613›Full record

ArticleClinical lung cancer2024

Brief Report: Impact of Anti-Cancer Treatments on Outcomes of COVID-19 in Patients With Thoracic Cancers: A CCC19 Registry Analysis.

Amit A Kulkarni, Cassandra Hennessy, Grace Wilson, Vidhyalakshmi Ramesh, Clara Hwang, Joy Awosika, Ziad Bakouny, Hina Khan, Diana Vilar-Compte, Rana McKay and 22 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical lung cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Amit A KulkarniUniversity of Minnesota, Minneapolis, MN. Electronic address: kulkarni@umn.edu.
Cassandra HennessyVanderbilt University Medical Center, Nashville, TN.
Grace WilsonUniversity of Minnesota, Minneapolis, MN.
Vidhyalakshmi RameshUniversity of Minnesota, Minneapolis, MN.
Clara HwangHenry Ford Health System, Detroit, MI.
Joy AwosikaUniversity of Cincinnati, Cincinnati, OH.
Ziad BakounyDana-Farber Cancer Institute, Boston, MA.
Hina KhanLegorreta Cancer Center at Brown University, Providence, RI.
Diana Vilar-CompteInstituto Nacional de Cancerologia, Mexico City, Mexico.
Rana McKayUniversity of California, San Diego, CA.
Chinmay JaniMount Auburn Hospital, Cambridge, MA.
Lisa WeissmannMount Auburn Hospital, Cambridge, MA.
Elizabeth GriffithsRosewell Park Comprehensive Cancer Center, Buffalo, NY.
Gerald BatistSegal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Canada.
Nathaniel BouganimSegal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Canada.
Blanche MavromatisUPMC Western Maryland, Cumberland, MD.
Babar BashirSidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, PA.
Ryan H NguyenUniversity of Illinois Hospital & Health Sciences System, Chicago, IL.
Jonathan W RiessUniversity of California Davis Comprehensive Cancer Center, Sacramento, CA.
Matthew PucVirtua Health, Marlton, NJ.
Anup KasiUniversity of Kansas, Kansas City, KS.
Stephanie BergLoyola University, Chicago, IL.
Dan Ran CastilloLoma Linda University, Loma Linda, CA.
Brandon Hayes-LattinOregon Health and Science University, Portland, OR.
Wylie HosmerHartford HealthCare Cancer Institute, Southington, CT.
Daniel FloraSt. Elizabeth Healthcare, Edgewood, KY.
Sanjay MishraLegorreta Cancer Center at Brown University, Providence, RI.
Benjamin FrenchVanderbilt University Medical Center, Nashville, TN.
Jeremy L WarnerLegorreta Cancer Center at Brown University, Providence, RI.
Gilberto LopesUniversity of Miami, Miami, FL.
Solange PetersCentre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
Narjust FlorezDana-Farber Brigham Cancer Center, Boston, MA.

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Ben Ho Park · 1995 to 2026
$172.8M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
The COVID-19 and Cancer Consortium (CCC19) RegistryU01CA287008 · NCI · RHODE ISLAND HOSPITAL · PI Sonya Reid, Jeremy L Warner · 2024 to 2026
$2.0M
NCATS NIH HHS UL1 TR000445NCI NIH HHS P30 CA068485NCI NIH HHS U01 CA287008
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19RegistriesSARS-CoV-2Thoracic NeoplasmsAgedAntineoplastic AgentsFemaleHumansMaleMiddle AgedAntineoplastic AgentsChemotherapyImmunotherapyTargeted therapyThoracic Cancers

Identifiers

PMID38744613
PMCPMC11213677

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.